Chagas Disease Megaesophagus Patients Carrying Variant MRPS18B P260A Display Nitro-Oxidative Stress and Mitochondrial Dysfunction in Response to IFN-γ Stimulus

Biomedicines. 2022 Sep 7;10(9):2215. doi: 10.3390/biomedicines10092215.

Abstract

Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, affects 8 million people, and around 1/3 develop chronic cardiac (CCC) or digestive disease (megaesophagus/megacolon), while the majority remain asymptomatic, in the indeterminate form of Chagas disease (ASY). Most CCC cases in families with multiple Chagas disease patients carry damaging mutations in mitochondrial genes. We searched for exonic mutations associated to chagasic megaesophagus (CME) in genes essential to mitochondrial processes. We performed whole exome sequencing of 13 CME and 45 ASY patients. We found the damaging variant MRPS18B 688C > G P230A, in five out of the 13 CME patients (one of them being homozygous; 38.4%), while the variant appeared in one out of 45 ASY patients (2.2%). We analyzed the interferon (IFN)-γ-induced nitro-oxidative stress and mitochondrial function of EBV-transformed lymphoblastoid cell lines. We found the CME carriers of the mutation displayed increased levels of nitrite and nitrated proteins; in addition, the homozygous (G/G) CME patient also showed increased mitochondrial superoxide and reduced levels of ATP production. The results suggest that pathogenic mitochondrial mutations may contribute to cytokine-induced nitro-oxidative stress and mitochondrial dysfunction. We hypothesize that, in mutation carriers, IFN-γ produced in the esophageal myenteric plexus might cause nitro-oxidative stress and mitochondrial dysfunction in neurons, contributing to megaesophagus.

Keywords: Chagas disease; MRPS18B; Trypanosoma cruzi; chagasic megaesophagus; interferon-gamma; mitochondria; mitochondrial dysfunction; mitochondrial mutation.

Grants and funding

This work received specific support from the funding body Fundação de Amparo à Pesquisa do Estado de S. Paulo (FAPESP 2019/22858-3). This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM); Aix-Marseille University (grant number: AMIDEX “International_2018” MITOMUTCHAGAS); the French Agency for Research (Agence Nationale de la Recherche—ANR) (grant numbers: “Br-Fr-Chagas”, “landscardio”); the Brazilian Council for Scientific and Technological Development (CNPq); the National Institutes of Health/USA (grant numbers: 2 P50 AI098461-02 and 2U19AI098461-06). This work was funded by the Inserm Cross-Cutting Project GOLD. This project has received funding from the Excellence Initiative of Aix-Marseille University—A*Midex a French “Investissements d’Avenir programme”—Institute MarMaRa AMX-19-IET-007. J.P.S.N. was a recipient of a MarMaRa fellowship. The funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.